MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies
Demographics (2)
- COLLECTION_AGE - Age sample was collected (phv00534193.v1.p1)
- SEX - Biological sex (phv00534185.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte type (phv00534190.v1.p1)
- BIOLOGICAL_SAMPLE_REPLICATE - Sample ID from which biological replicate was derived (phv00534198.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00534189.v1.p1)
- COLLECTION_DAYS_FROM_SURGERY - Days after curative-intent surgery sample was collected (phv00534194.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00534184.v1.p1)
- DESCRIPTION - Description of sample preparation (phv00534200.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00534192.v1.p1)
- IS_TUMOR - Tumor status (phv00534191.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00534195.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00534196.v1.p1)
- PROTOCOL - Sequencing protocol to which sample was subjected (phv00534199.v1.p1)
- SAMPLE_ID - Sample ID (phv00534188.v1.p1)
- SAMPLE_ID - Sample ID (phv00534187.v1.p1)
- SUBJECT_ID - Subject ID (phv00534183.v1.p1)
- SUBJECT_ID - Subject ID (phv00534186.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00534197.v1.p1)